Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. The US Court of Appeals for the Federal Circuit (CAFC) has ...

As the US and Europe experiences shortages of crucial medicines, Ben Hargreaves looks at how a once thriving generics industry is now struggling, with many companies seeking to exit the space. Generic ...

The Controller General of Patents, Designs and Trademarks (CGPDTM), the Indian Patent Office, has annulled the patent granted to Novartis for its cardiac drug Vymada, also sold internationally as ...

It’s never been easier to go somewhere, but at the same time, it’s also never been harder to say why. As the most well-travelled generation in history, we can effortlessly book a trip to the other ...

This tutorial shows how to build an automatic cow farm in Minecraft 1.20 and later, compatible with both Java and Bedrock Edition. Designed for survival mode, the build produces cooked beef and ...

Faced with the prospect of tariffs on imported medicines threatened by the Trump administration, Indian drugmaker Hikma has said it will spend $1 billion to expand its manufacturing and R&D operations ...

“Amgen’s takeaway is simple yet profound: The current system is working, and innovation is benefiting actual patients.” The ongoing policy debate about pharmaceutical and biologic patents has been ...

Inside the Velotech HQ in northeast Portland in 2014. (Photo: Jonathan Maus/BikePortland) Portland-based Velotech Inc. has been acquired by Backcountry. The sale was reported in Bicycle Retailer & ...

The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two months ...

Community driven content discussing all aspects of software development from DevOps to design patterns. One of the most secure ways to communicate across the public internet is to use SSH. This is why ...

Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The small-molecule PIKfyve inhibitor – called ...